Executive Summary
Investment Thesis (3 Sentences)
Zavarovalnica Triglav is the dominant insurer in Slovenia (40.8% market share) and the Adria region (20.6%), operating as a quasi-regulated oligopoly with 124+ years of operating history. Following a CAT-event-impacted 2023, the company has demonstrated strong recovery with ROE returning to 14%, combined ratio improving to 91%, and a 60% dividend increase. The stock trades at 10.5x earnings with a 4.8% yield, offering reasonable value for a quality regional insurer, though government control (62.56%) and illiquidity present governance and exit risks.
Key Metrics Dashboard
| Metric | Value | Assessment |
|---|---|---|
| Price | €58.60 | - |
| P/E (TTM) | 10.49x | Reasonable |
| P/B | 1.49x | Fair |
| Dividend Yield | 4.78% | Attractive |
| ROE (2024) | 14.0% | Near Buffett threshold |
| Combined Ratio | 91.0% | Excellent |
| Credit Rating | A (S&P, AM Best) | Investment Grade |
| Beta | 0.42 | Defensive |
Decision & Sizing
| Decision | Rationale |
|---|---|
| HOLD (Currently Owned at 7.19%) | Fair value range, no compelling reason to add or sell |
| Position Size | Appropriate - no change recommended |
Primary Catalyst & Timeline
- Catalyst: Continued dividend growth as 2025 guidance suggests maintaining upper-end profitability
- Timeline: Ex-dividend June 16, 2025 (€2.80/share proposed)
PHASE 0: Opportunity Identification (Klarman)
Why Does This Opportunity Exist?
| Opportunity Source | Present? | Notes |
|---|---|---|
| Forced selling | No | - |
| Complexity/stigma | Partial | Ljubljana Stock Exchange is illiquid and off most investors' radar |
| Institutional constraints | Yes | Too small for large funds, no ADR, limited analyst coverage |
| Temporary operational problem | Resolved | 2023 CAT events now in rearview |
| Market overreaction | No | Stock up +46% YTD, market has recognized recovery |
| Neglect | Yes | Minimal English-language analyst coverage |
Assessment: The opportunity existed primarily due to (1) illiquidity/neglect from the Ljubljana Stock Exchange being off the beaten path, and (2) temporary CAT event impact in 2023. The market has now largely recognized the recovery (stock +46% YTD), reducing the opportunity.
PHASE 1: Risk Analysis (Inversion Thinking)
"All I want to know is where I'm going to die, so I'll never go there." - Munger
Top 3 Ways This Investment Could Fail
1. Government Control Risk (Probability: 20% | Impact: -30%)
- Risk: State holds 62.56% through ZPIZ (34.47%) and SDH (28.09%)
- Mechanism: Political interference in underwriting, dividend policy, or strategic decisions
- Historical Evidence: No major interference to date, but political changes could alter dynamics
- Mitigation: Long history of professional management; government has financial incentive in dividends
- Expected Loss: 20% × 30% = 6%
2. Catastrophe Event Recurrence (Probability: 25% | Impact: -40%)
- Risk: Slovenia/Balkans exposed to floods, storms (as seen in 2023)
- Mechanism: Large claims → combined ratio >100% → earnings destruction → dividend cut
- Historical Evidence: 2023 combined ratio hit 101.6%, ROE collapsed to 1.8%
- Mitigation: Reinsurance program, ~225% solvency ratio provides buffer
- Expected Loss: 25% × 40% = 10%
3. Liquidity/Exit Risk (Probability: 15% | Impact: -25%)
- Risk: Ljubljana Stock Exchange is illiquid; large sales could move price significantly
- Mechanism: Need to sell → price impact → realized loss below NAV
- Current Position: 7.19% of portfolio = manageable but not trivial
- Mitigation: Long holding period assumed; patient exit over time
- Expected Loss: 15% × 25% = 3.75%
Bear Case Summary (Short Thesis)
"Triglav is a government-controlled insurer in an illiquid market, exposed to Balkans geopolitical risk and climate catastrophes. With 62% state ownership, minority shareholders have limited influence. The 2024 recovery is the aberration; normalized ROE is closer to 8-10%, not 14%. At 1.5x book, you're paying full price for a mediocre insurer with governance discount deserved."
Inversion Questions
| Question | Answer |
|---|---|
| How could this lose 50%+ permanently? | Major CAT + political interference + forced nationalization or dilutive capital raise |
| Non-price sell triggers? | Government signals intent to restructure; management materially increases risk appetite; combined ratio >100% for 2 consecutive years |
| 3-sentence bear case? | See above |
| Can I state bear case better than bears? | Yes - the bear case is real but manageable given solvency levels |
PHASE 2: Financial Analysis
Return Metrics
ROE Analysis (5-Year)
| Year | ROE | Assessment |
|---|---|---|
| 2024 | 14.0% | Near Buffett 15% threshold |
| 2023 | 1.8% | CAT event impact |
| 2022 | -0.7% | CAT + IFRS transition |
| 2021 | ~9.5% | Normal |
| 2020 | ~8.0% | COVID impact |
Normalized ROE: ~10-11% (excluding CAT events and best years)
DuPont Decomposition (2024E):
- Net Profit Margin: ~7.6% (€131M / €1,720M)
- Asset Turnover: 0.42x (€1,720M / €4,099M assets)
- Equity Multiplier: 4.6x (€4,099M / €891M equity)
- ROE = 7.6% × 0.42 × 4.6 = 14.7% ✓ Confirms reported 14%
Owner Earnings Calculation (2024E)
Net Earnings: €131.4M
+ Depreciation/Amortization: ~€15M (estimated)
- Maintenance CapEx: ~€10M (estimated)
= Owner Earnings: ~€136M
Owner Earnings per Share = €136M / 22.71M = €5.99
Valuation Trinity
1. Liquidation Value (Floor)
For an insurer, liquidation value is complex due to policy liabilities.
Tangible Book Value = Total Equity - Goodwill/Intangibles
= €891M - ~€50M = ~€841M
Tangible Book Value per Share = €841M / 22.71M = €37.03
Current Price €58.60 vs TBV €37.03 = 1.58x P/TBV
Assessment: Trading at premium to tangible book - not a net-net opportunity.
2. Going Concern Value (DCF Conservative)
Assumptions:
- Owner Earnings Year 0: €136M
- Growth Years 1-5: 3% (inflation + modest growth)
- Growth Years 6-10: 2% (mature market)
- Terminal Growth: 1.5%
- Discount Rate: 10% (EUR equity + small country risk)
DCF Value (10-year):
Year 1-5: €136M growing at 3% = €140, €144, €149, €153, €158
Year 6-10: Growing at 2% = €161, €164, €167, €171, €174
Terminal Value = €174 × 1.015 / (0.10 - 0.015) = €2,077M
PV of Cash Flows + Terminal = ~€1,100M + €801M = €1,901M
Intrinsic Value = €1,901M / 22.71M = €83.70 per share
Margin of Safety: (€83.70 - €58.60) / €83.70 = 30%
3. Private Market Value (What Would a Buyer Pay?)
European insurance M&A typically occurs at:
- 1.0-1.5x book for average insurers
- 1.5-2.0x book for market leaders with clean balance sheets
Triglav has:
- Regional dominance (40.8% Slovenia)
- Clean balance sheet (225% solvency)
- A-rated by S&P and AM Best
Private Market Multiple: 1.6-1.8x book value reasonable
PMV = €39.24 BVPS × 1.7 = €66.71 per share
Current Price vs PMV: €58.60 / €66.71 = 12% discount
4. Relative Valuation
| Metric | ZVTG | European Insurers Avg |
|---|---|---|
| P/E | 10.5x | 9-12x |
| P/B | 1.49x | 1.0-1.5x |
| Dividend Yield | 4.8% | 4-6% |
| Combined Ratio | 91% | 94-98% |
Assessment: Trading in line with peers on P/E, slight premium on P/B justified by superior combined ratio.
Valuation Summary
| Method | Value/Share | vs €58.60 | MOS |
|---|---|---|---|
| Tangible Book Value | €37.03 | +58% premium | n/a |
| DCF (Conservative) | €83.70 | -30% discount | 30% |
| Private Market Value | €66.71 | -12% discount | 12% |
| Owner Earnings × 10 | €59.90 | -2% discount | 2% |
| Owner Earnings × 12 | €71.88 | -18% discount | 18% |
Intrinsic Value Estimate: €68-72 per share (weighted average of methods) Current Margin of Safety: ~15-18% (moderate)
PHASE 3: Moat Analysis
Moat Sources
| Moat Type | Strength | Evidence |
|---|---|---|
| Regional Dominance | HIGH | 40.8% Slovenia, 20.6% Adria - #1 in both |
| Scale Advantages | MODERATE | Cost spread across largest customer base in region |
| Brand/Trust | HIGH | 124+ years of operations, government backing |
| Regulatory Barriers | MODERATE | Insurance licensing creates barrier to entry |
| Switching Costs | LOW-MODERATE | Policies annual but relationships sticky |
Moat Durability Assessment
| Threat | Severity (1-5) | Timeline | Company Mitigation |
|---|---|---|---|
| Technology disruption (InsurTech) | 2 | 5-10 years | Investing in digital; local market protected |
| Regulatory change | 2 | Ongoing | Government ownership = alignment |
| New entrants | 2 | Low probability | Dominant share makes entry unattractive |
| Customer power shift | 3 | Gradual | Price comparison sites increasing pressure |
| Climate/CAT events | 4 | Recurring | Reinsurance + solvency buffers |
10-Year Moat Trajectory: Stable (neither widening nor narrowing materially)
Moat Rating: MODERATE
Dominant regional position is real but:
- Not a "Coca-Cola" level brand moat
- Insurance is inherently competitive on price
- Geographic concentration = undiversified
PHASE 4: Management & Incentive Analysis
Executive Team
| Name | Position | Tenure | Assessment |
|---|---|---|---|
| Andrej Slapar | CEO | 2013 (11+ years) | Long tenure, stable |
| Tadej Coroli | CFO | 2014 (10+ years) | Continuity |
| Marica Makoter | Corporate Officer | 2011 (13+ years) | Institutional knowledge |
Tenure Assessment: Exceptionally stable leadership team with deep institutional knowledge.
Capital Allocation Track Record
| Use of FCF | % (Est.) | Assessment |
|---|---|---|
| Dividends | ~50% | Increasing (€2.80 proposed, +60% YoY) |
| Retained Earnings | ~40% | Maintaining solvency buffer |
| M&A | ~10% | Modest regional acquisitions |
Dividend Policy: Balanced between shareholder returns and growth - appropriate for mature market leader.
Insider Activity
Limited visibility on Ljubljana Stock Exchange - no Form 4 equivalent readily available.
Government Ownership Considerations
Risks:
- Political appointment of supervisory board members
- Pressure to maintain employment regardless of efficiency
- Strategic decisions may favor national interest over shareholders
Mitigants:
- Professional management team with long tenure
- Listed company with minority shareholders = some discipline
- Government benefits from dividends (pension fund is largest holder)
- No evidence of value-destructive interference historically
PHASE 5: Catalyst Analysis
Potential Catalysts
| Catalyst | Type | Timeline | Probability | Impact |
|---|---|---|---|---|
| €2.80 dividend payment | Internal | June 2025 | 95% | Modest (priced in) |
| Continued earnings recovery | Operational | 2025 | 70% | Moderate |
| EU green/sustainable insurance tailwinds | External | 2-5 years | 50% | Moderate |
| Regional consolidation (acquirer or acquiree) | External | Uncertain | 20% | High |
| Privatization of government stake | External | Low probability | 10% | High |
No Catalyst Assessment
Currently no strong near-term catalyst beyond dividend. The story is already largely reflected in price (+46% YTD).
Implication: Larger margin of safety required or accept that this is a dividend-income holding, not a deep-value opportunity.
PHASE 6: Decision Synthesis
Graham's 7 Criteria Assessment
| # | Criterion | Test | ZVTG | Pass? |
|---|---|---|---|---|
| 1 | Adequate Size | Sales > €100M | €1,720M GWP | ✅ |
| 2 | Financial Condition | Solvency strong | 225% solvency | ✅ |
| 3 | Earnings Stability | Positive 10 years | 2022-2023 losses | ❌ |
| 4 | Dividend Record | 20+ years | ~20 years | ✅ |
| 5 | Earnings Growth | 33% over 10 years | Volatile | ⚠️ |
| 6 | Moderate P/E | P/E < 15 | 10.5x | ✅ |
| 7 | Moderate P/B | P/B < 1.5 or P/E × P/B < 22.5 | 10.5 × 1.49 = 15.6 | ✅ |
Graham Quality: 5/7 passed - acceptable but not "defensive grade"
Buffett Quality Criteria
| Criterion | Assessment | Pass? |
|---|---|---|
| Explain in one sentence | "Largest insurer in Slovenia/Balkans" | ✅ |
| ROE consistently > 15%? | Normalized ~10-11%, exceptional years hit 14% | ❌ |
| Management skin in game? | Government ownership, limited personal stake visible | ⚠️ |
| Identifiable moat? | Regional dominance + brand | ✅ |
| Consistent FCF? | Volatile due to CAT events | ⚠️ |
Buffett Quality: 2.5/5 - Mediocre
Megatrend Resilience Score
| Megatrend | Score | Notes |
|---|---|---|
| China Tech Superiority | +1 | Immune - local market |
| Europe Degrowth | -1 | Slovenia tied to EU economy |
| American Protectionism | 0 | Neutral - no US exposure |
| AI/Automation | 0 | Claims processing may benefit |
| Demographics/Aging | +1 | Life insurance demand |
| Fiscal Crisis | 0 | Neutral |
| Energy Transition | 0 | Neutral |
Total Score: +1 | Tier: T3 (Adaptable)
Expected Return with Probability Tree
| Scenario | Probability | 5-Year Return | Weighted |
|---|---|---|---|
| Bull (normalized ROE 14%+, multiple expansion) | 20% | +80% | +16% |
| Base (normalized ROE 10-12%, dividends reinvested) | 50% | +40% | +20% |
| Bear (CAT events, combined ratio >100%) | 25% | -10% | -2.5% |
| Disaster (government interference, forced sale) | 5% | -50% | -2.5% |
| Expected | 100% | +31% |
5-Year Expected Return: +31% (~5.5% annualized + 5% dividend = ~10.5% total return)
Position Sizing
Current position: 7.19% of portfolio
Assessment: Position size is appropriate given:
- Moderate moat (not T1)
- Illiquidity risk
- Government control discount warranted
- Already up +25% - not adding at current levels
Recommendation: HOLD at current size
Price Targets & Recommendation
┌─────────────────────────────────────────────────────────────────┐
│ INVESTMENT RECOMMENDATION │
├─────────────────────────────────────────────────────────────────┤
│ Company: Zavarovalnica Triglav Ticker: ZVTG │
│ Current Price: €58.60 Date: December 24, 2024 │
├─────────────────────────────────────────────────────────────────┤
│ VALUATION SUMMARY │
│ ┌─────────────────────────┬─────────────┬─────────────────────┐ │
│ │ Method │ Value/Share │ vs Current Price │ │
│ ├─────────────────────────┼─────────────┼─────────────────────┤ │
│ │ Tangible Book Value │ €37.03 │ +58% premium │ │
│ │ DCF (Conservative) │ €83.70 │ 30% MOS │ │
│ │ Private Market Value │ €66.71 │ 12% MOS │ │
│ │ Owner Earnings (10x) │ €59.90 │ 2% MOS │ │
│ │ Owner Earnings (12x) │ €71.88 │ 18% MOS │ │
│ └─────────────────────────┴─────────────┴─────────────────────┘ │
│ │
│ INTRINSIC VALUE ESTIMATE: €70 (rounded weighted average) │
│ CURRENT MARGIN OF SAFETY: 16% │
├─────────────────────────────────────────────────────────────────┤
│ RECOMMENDATION: [ ] BUY [x] HOLD [ ] SELL [ ] WAIT │
├─────────────────────────────────────────────────────────────────┤
│ BUY PRICE (Strong): €49.00 (30% below IV) │
│ ACCUMULATE PRICE: €56.00 (20% below IV) │
│ FAIR VALUE: €70.00 (Intrinsic Value) │
│ TAKE PROFITS PRICE: €84.00 (20% above IV) │
│ SELL PRICE: €105.00 (50% above IV) │
├─────────────────────────────────────────────────────────────────┤
│ POSITION SIZE: 7.19% (current) - maintain, no change │
│ CATALYST: Dividend payment June 2025; continued earnings growth │
│ PRIMARY RISK: CAT events + government control │
│ SELL TRIGGER: Combined ratio >100% for 2 years; government │
│ signals restructuring; dividend cut >30% │
└─────────────────────────────────────────────────────────────────┘
Explicit Sell Triggers
- Thesis Break: Government announces material change to ownership structure or dividend policy
- Moat Erosion: Market share falls below 35% in Slovenia
- Management Failure: CEO replaced by political appointee with no insurance experience
- Valuation: Price exceeds €105 (50% above fair value)
- Financial: Combined ratio >100% for 2 consecutive years
What I Will NOT Sell On
- Single CAT event (reinsurance covers)
- Short-term price drops without fundamental change
- Market volatility in Ljubljana Stock Exchange
- Macro concerns about Eurozone (Slovenia is well-integrated)
Monitoring Metrics
| Metric | Current | Warning | Action if Breached |
|---|---|---|---|
| Combined Ratio | 91% | >98% | Watch closely |
| ROE | 14% | <8% | Review thesis |
| Solvency Ratio | 225% | <180% | Concern |
| Dividend/Share | €2.80 | <€2.00 | Review thesis |
| Market Share (Slovenia) | 40.8% | <35% | Moat erosion signal |
Psychology Check
| Bias | Check | Status |
|---|---|---|
| Social proof | Am I holding because it's in portfolio? | ⚠️ Slight risk |
| Commitment/consistency | Am I ignoring negatives? | No - acknowledging mediocre quality |
| Excessive self-regard | Overconfident in analysis? | Acknowledged limited data sources |
| Endowment effect | Holding because I own it? | Possibly - but position size is reasonable |
Munger's Final Test
- Circle of Competence: Can explain - regional insurer with dominant market share
- Variant Perception: Market correctly values this as moderate-quality insurer; no edge
- Humility Check: If CAT events become more frequent due to climate change, thesis is damaged
- Inversion Final: If -50% tomorrow, would add cautiously but not aggressive (moderate conviction)
Sources Used & Data Extracted
Web Sources Consulted
| Source | Data Extracted |
|---|---|
| StockAnalysis.com | Price, P/E, EPS, dividend, market cap |
| MarketScreener.com | Forecasts, analyst ratings, ownership |
| Triglav Investor Relations | 2024 results, guidance, dividend policy |
| Triglav Annual Report 2023 | Financial highlights, combined ratio, ROE |
| AM Best (via Morningstar) | Credit ratings |
| Wikipedia | Market share, history, ownership |
Data Limitations
- Ljubljana Stock Exchange: Not covered by AlphaVantage or EODHD APIs
- SEC Filings: Not available (Slovenian company)
- Detailed Annual Reports: Would require manual PDF download from Triglav IR
- Insider Transactions: Not readily available for LJSE
Data Validation
| Metric | Primary Source | Cross-Check | Consistent? |
|---|---|---|---|
| ROE 14% | Triglav IR | AM Best, MarketScreener | Yes |
| Combined Ratio 91% | Triglav IR | Annual Report | Yes |
| P/E 10.49x | StockAnalysis | MarketScreener | Yes |
| Market Share 40.8% | Triglav IR | Wikipedia | Yes |
Conclusion
Zavarovalnica Triglav is a moderate-quality regional insurer with dominant market position but several structural constraints (government control, illiquidity, CAT exposure). The current price of €58.60 represents fair value with a modest 16% margin of safety - not compelling for new purchases but appropriate to hold for income and modest appreciation.
Final Verdict: HOLD at current allocation. Collect dividends (4.8% yield). Would consider adding only below €50.
Analysis completed December 24, 2024